Selected article for: "APMV replication and non human primate"
Author: Khattar, Sunil K.; Nayak, Baibaswata; Kim, Shin-Hee; Xiao, Sa; Samal, Sweety; Paldurai, Anandan; Buchholz, Ursula J.; Collins, Peter L.; Samal, Siba K.
Title: Evaluation of the Replication, Pathogenicity, and Immunogenicity of Avian Paramyxovirus (APMV) Serotypes 2, 3, 4, 5, 7, and 9 in Rhesus Macaques
  • Document date: 2013_10_10
    • ID: 0littefv_42
    Snippet: In summary, we have evaluated the replication and pathogenicity of APMV serotypes-2, -3, -4, -5, -7, and -9 in non-human primates. These respiratory viruses are highly restricted for replication in respiratory tract of rhesus macaques. We have also demonstrated a substantial level of immunogenicity for wt APMV-2, -3 -7 and -9 and recombinant wt APMV-4, APMV-4/Fc-BC, and APMV-7/Fcs-5B in this non-human primate model. As these APMVs are serological.....
    Document: In summary, we have evaluated the replication and pathogenicity of APMV serotypes-2, -3, -4, -5, -7, and -9 in non-human primates. These respiratory viruses are highly restricted for replication in respiratory tract of rhesus macaques. We have also demonstrated a substantial level of immunogenicity for wt APMV-2, -3 -7 and -9 and recombinant wt APMV-4, APMV-4/Fc-BC, and APMV-7/Fcs-5B in this non-human primate model. As these APMVs are serologically distinct from NDV and from each other, they may be developed as vectors and used in heterologous primeboost combinations to induce robust systemic and mucosal immune responses against foreign antigens.

    Search related documents:
    Co phrase search for related documents
    • APMV pathogenicity replication and non human primate model: 1
    • APMV pathogenicity replication and pathogenicity replication: 1, 2, 3, 4, 5
    • APMV pathogenicity replication and primate model: 1
    • APMV pathogenicity replication and respiratory tract: 1
    • APMV pathogenicity replication evaluate and non human primate: 1
    • APMV pathogenicity replication evaluate and non human primate model: 1
    • APMV pathogenicity replication evaluate and pathogenicity replication: 1, 2
    • APMV pathogenicity replication evaluate and primate model: 1
    • foreign antigen and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • foreign antigen and pathogenicity replication: 1
    • foreign antigen and respiratory tract: 1
    • foreign antigen immune response and immune response: 1, 2, 3
    • immune response and non human primate model: 1, 2, 3
    • immune response and primate model: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • immune response and respiratory tract: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • immune response and respiratory virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • immune response and rhesus macaque: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • immune response and substantial level: 1, 2
    • immune response and vector develop: 1, 2, 3